Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
J Cardiovasc Electrophysiol ; 20(2): 238-40, 2009 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-19175842

RESUMEN

Transseptal puncture is a standard means of catheter access to the left atrium via the venous system, but carries a risk of cardiac perforation. Stretching and increased force to traverse the septum are required with elastic, aneurysmal, or thickened interatrial tissue. We describe a technique that facilitates transseptal puncture by applying brief pulses of radiofrequency energy from a standard electrosurgical cautery generator through the needle tip.


Asunto(s)
Ablación por Catéter/métodos , Tabiques Cardíacos/cirugía , Ablación por Catéter/instrumentación , Tabiques Cardíacos/anatomía & histología , Humanos , Agujas
2.
Pacing Clin Electrophysiol ; 31(7): 828-37, 2008 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-18684279

RESUMEN

BACKGROUND: The dual chamber and VVI implantable defibrillator (DAVID) trial demonstrated that dual chamber (DDDR) pacing in defibrillator candidates with impaired ventricular function and no established indication for pacing resulted in worsened congestive heart failure (CHF) or death. Many patients had abnormalities for which pacing is often advocated to improve the management of ventricular dysfunction. OBJECTIVES: Evaluate the impact and interaction of nonessential but potentially justifiable reasons to pace ("soft indications"), together with pacing mode, on outcome. METHODS: DAVID patients were stratified by those with and without "soft indications" for pacing (rate < 60 beats/min or first-degree atrioventricular block) (n = 169; n = 335, respectively). This analysis also stratified patients by normal and abnormal QRS conduction (QRS >or= 110 ms), who were previously found to be affected differently by DDDR pacing. Groups were analyzed according to the combined endpoint of mortality or CHF hospitalization. RESULTS: When assigned to treatment that promoted pacing (DDDR), the incidence of death or CHF tended to be higher in patient subgroups with and without "soft indications," consistent with results from DAVID. Patients with, compared to those without, these abnormalities neither benefited nor were less adversely affected when actively paced. The presence or absence of "soft indications" also provided no additional explanation for the differing outcomes in patient cohorts with and without abnormal QRS conduction. CONCLUSIONS: Sinus bradycardia or first-degree atrioventricular block did not ameliorate the poor outcomes associated with dual-chamber compared with VVI pacing, and do not justify conventional dual-chamber pacing in defibrillator recipients with ventricular dysfunction.


Asunto(s)
Estimulación Cardíaca Artificial/mortalidad , Desfibriladores Implantables/estadística & datos numéricos , Cardioversión Eléctrica/mortalidad , Insuficiencia Cardíaca/mortalidad , Insuficiencia Cardíaca/prevención & control , Medición de Riesgo/métodos , Anciano , Femenino , Humanos , Incidencia , Masculino , Persona de Mediana Edad , Pronóstico , Factores de Riesgo , Método Simple Ciego , Análisis de Supervivencia , Tasa de Supervivencia , Resultado del Tratamiento , Estados Unidos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA